Catalent, a multinational corporation, agreed to acquire Metrics Contract Services, a company which provides resources and capabilities along with the high standards of scientific excellence and staff experience, from Mayne Pharma, a pharmaceutical company, for $475m. “This acquisition will further expand Catalent’s ability to meet our customers’ expectations in fast-growing areas of the business and patient need. The experienced team and consistently improved, state-of-the-art facility in Greenville will provide Catalent’s customers with immediate, fit-for-scale capacity for in-demand highly potent drugs and other oral solid small-to-mid-size batch needs. This capacity is particularly important for customers with R&D pipelines featuring accelerated, orphan, and rare disease programs for oncology and other important therapeutic areas,” Aris Gennadios, Catalent President.